Anticoagulation After Stroke in Patients With Atrial Fibrillation-Reference-Cited by-同舟云学术

Anticoagulation After Stroke in Patients With Atrial Fibrillation

Published:2019-08 Issue:8 Volume:50 Page:2093-2100
ISSN:0039-2499
Container-title:Stroke
language:en
Short-container-title:Stroke

Author:

Altavilla Riccardo¹,Caso Valeria¹,Bandini Fabio²,Agnelli Giancarlo¹,Tsivgoulis Georgios³⁴,Yaghi Shadi⁵,Furie Karen L.⁵,Tadi Prasanna⁵,Becattini Cecilia¹,Zedde Marialuisa⁵,Abdul-Rahim Azmil H.⁶,Lees Kennedy R.⁶,Alberti Andrea¹,Venti Michele¹,Acciarresi Monica¹,D’Amore Cataldo¹,Giulia Mosconi Maria¹,Anna Cimini Ludovica¹,Fusaro Jessica¹,Bovi Paolo⁷,Carletti Monica⁷,Rigatelli Alberto⁷,Cappellari Manuel⁷,Putaala Jukka⁸,Tomppo Liisa⁸,Tatlisumak Turgut⁸⁹¹⁰,Marcheselli Simona¹¹,Pezzini Alessandro¹²,Poli Loris¹²,Padovani Alessandro¹²,Masotti Luca¹³,Vannucchi Vieri¹³,Sohn Sung-Il¹⁴,Lorenzini Gianni¹⁵,Tassi Rossana¹⁶,Guideri Francesca¹⁶,Acampa Maurizio¹⁶,Martini Giuseppe¹⁶,Ntaios George¹⁷,Athanasakis George¹⁷,Makaritsis Konstantinos¹⁷,Karagkiozi Efstathia¹⁷,Vadikolias Konstantinos¹⁸,Liantinioti Chrysoula⁴,Chondrogianni Maria⁴,Mumoli Nicola¹⁹,Consoli Domenico²⁰,Galati Franco²⁰,Sacco Simona²¹,Carolei Antonio²¹,Tiseo Cindy²¹,Corea Francesco²²,Ageno Walter²³,Bellesini Marta²³,Silvestrelli Giorgio²⁴,Ciccone Alfonso²⁴,Lanari Alessia²⁴,Scoditti Umberto²⁵,Denti Licia²⁶,Mancuso Michelangelo²⁷,Maccarrone Miriam²⁷,Ulivi Leonardo²⁷,Orlandi Giovanni²⁷²⁸,Giannini Nicola²⁷,Gialdini Gino²⁷,Tassinari Tiziana²⁹,De Lodovici Maria Luisa³⁰,Bono Giorgio³⁰,Rueckert Christina³¹,Baldi Antonio³²,D’Anna Sebastiano³²,Toni Danilo³³,Letteri Federica³³,Giuntini Martina²⁸,Maria Lotti Enrico³⁴,Flomin Yuriy³⁵,Pieroni Alessio³³,Kargiotis Odysseas³⁶,Karapanayiotides Theodore³⁷,Monaco Serena³⁸,Maimone Baronello Mario³⁸,Csiba Laszló³⁹,Szabó Lilla³⁹,Chiti Alberto²⁷⁴⁰,Giorli Elisa⁴⁰,Del Sette Massimo⁴⁰⁴¹,Imberti Davide⁴²,Zabzuni Dorjan⁴²,Doronin Boris⁴³,Volodina Vera⁴³,Michel Patrik⁴⁴,Vanacker Peter⁴⁵,Barlinn Kristian⁴⁶,Pallesen Lars-Peder⁴⁶,Barlinn Jessica⁴⁶,Deleu Dirk⁴⁷,Melikyan Gayane⁴⁷,Ibrahim Faisal⁴⁷,Akhtar Naveed⁴⁷,Gourbali Vanessa⁴⁸,Paciaroni Maurizio¹

Affiliation:

1. From the Stroke Unit and Division of Cardiovascular Medicine, University of Perugia, Italy (R.A., V.C., G.A., C.B., A.A., M.V., M.A., C.D., M.G.M., L.A.C., J.F., M.P.)

2. Department of Neurology, Ospedale San Paolo, Savona, Italy (F.B.)

3. Department of Neurology, University of Tennessee Health Science Center, Memphis (G.T.)

4. Second Department of Neurology, Attikon University Hospital, National and Kapodistrian University of Athens, School of Medicine, Greece (G.T., C.L., M. Chondrogianni)

5. Neurology Unit, Stroke Unit, Arcispedale Santa Maria Nuova, Azienda Unità Sanitaria Locale–IRCCS, Reggio Emilia, Italy (M.Z.)

6. Medical School and Institute of Cardiovascular and Medical Sciences, University of Glasgow, United Kingdom (A.H.A.-R., K.R.L.)

7. SSO Stroke Unit, UO Neurologia, DAI di Neuroscienze, AOUI Verona, Italy (P.B., M. Carletti, A.R., M. Cappellari)

8. Department of Neurology, Helsinki University Central Hospital, Finland (J.P., L.T., T.T.)

9. Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Sweden (T.T.)

10. Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden (T.T.)

11. Neurologia d’urgenza e Stroke Unit, Istituto Clinico Humanitas, Rozzano, Milano, Italy (S.M.)

12. Department of Clinical and Experimental Sciences, Neurology Unit, University of Brescia, Italy (A. Pezzini, L.P., A. Padovani)

13. Internal Medicine, Santa Maria Nuova Hospital, Firenze, Italy (L.M., V.V.)

14. Department of Neurology, Keimyung University School of Medicine, Daegu, South Korea (S.I.S.)

15. SC Medicina e Chirurgia d’Accettazione e d’Urgenza, Ospedale Lotti Pontedera, Azienda USL Toscana Nordovest, Pisa, Italy (G.L.)

16. Stroke Unit, AOU Senese, Siena, Italy (R.T., F.G., M.A., G. Martini)

17. Department of Medicine, University of Thessaly, Larissa, Greece (G.N., G.A., K.M., E.K.)

18. Department of Neurology, Democritus University of Thrace, University Hospital of Alexandroupolis, Greece (K.V.)

19. Department of Internal Medicine, Ospedale Civile di Livorno, Italy (N.M.)

20. Stroke Unit, Jazzolino Hospital, Vibo Valentia, Italy (D.C., F.G.)

21. Department of Neurology, University of L’Aquila, Avezzano Hospital, Italy (S.S., A. Carolei, C.T.)

22. UO Gravi Cerebrolesioni, San Giovanni Battista Hospital, Foligno, Italy (F.C.)

23. Department of Internal Medicine, Insubria University, Varese, Italy (W.A., M.B.)

24. S.C. di Neurologia e S.S. di Stroke Unit, ASST di Mantova, Italy (G.S., A. Ciccone, A.L.)

25. Stroke Unit, Neuroscience Department (U.S.), University of Parma, Italy

26. Stroke Unit, Dipartimento Geriatrico Riabilitativo (L.D.), University of Parma, Italy

27. Clinica Neurologica, Azienda Ospedaliero Universitaria, Pisa, Italy (M. Mancuso, M. Maccarrone, L.U., G.O., N.G., G.G., A.C.)

28. Neurologia, Ospedale Apuano, Massa Carrara, Italy (G.O., M.G.)

29. Stroke Unit, Department of Neurology, Santa Corona Hospital, Pietra Ligure (Savona), Italy (T.T.)

30. Stroke Unit, Department of Neurology, Insubria University, Varese, Italy (M.L.D.L., G.B.)

31. Abteilung für Neurologie, Oberschwabenklinik gGmbH, Ravensburg, Germany (C.R.)

32. Stroke Unit, Ospedale di Portogruaro, Venice, Italy (A.B., S.D.)

33. Department of Neurology and Psychiatry, Sapienza University of Rome, Italy (D.T., F.L., A.P.)

34. U.O. Neurologia Presidio Ospedaliero di Ravenna Azienda USL della Romagna, Italy (E.M.L.)

35. Stroke and Neurorehabilitation Unit, MC Universal Clinic ‘Oberig’, Kyiv, Ukraine (Y.F.)

36. Stroke Unit, Metropolitan Hospital, Piraeus, Greece (O.K.)

37. 2nd Department of Neurology, AHEPA University Hospital, Thessaloniki, Greece (T.K.)

38. Stroke Unit, Ospedale Civico, Palermo, Italy (S.M., M.M.B.)

39. Stroke Unit, University of Debrecen, Hungary (L.C., L.S.)

40. Stroke Unit, Department of Neurology, Sant’Andrea Hospital, La Spezia, Italy (A.C., E.G., M.D.S.)

41. Divisione di Neurologia, Ospedale Galliera, Genoa, Italy (M.D.S.)

42. Department of Internal Medicine, Ospedale Civile di Piacenza, Italy (D.I., D.Z.)

43. Municipal Budgetary Healthcare Institution of Novosibirsk, City Clinical Hospital No. 1, Novosibirsk State Medical University, Russia (B.D., V.V.)

44. Département des Neurosciences Cliniques, Centre Cérébrovasculaire, Service de Neurologie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.)

45. Department of Neurology, Born Bunge Institute, Antwerp University Hospital, Belgium (P.V.)

46. Department of Neurology, Dresden University Stroke Center, Germany (K.B., L.-P.P., J.B.)

47. Neurology, Hamad Medical Corporation, Doha, Qatar (D.D., G. Melikyan, F.I., N.A.)

48. Department of Neurology, Evangelismos Hospital, Athens (V.G.).

Abstract

Background and Purpose— Bridging therapy with low-molecular-weight heparin reportedly leads to a worse outcome for acute cardioembolic stroke patients because of a higher incidence of intracerebral bleeding. However, this practice is common in clinical settings. This observational study aimed to compare (1) the clinical profiles of patients receiving and not receiving bridging therapy, (2) overall group outcomes, and (3) outcomes according to the type of anticoagulant prescribed. Methods— We analyzed data of patients from the prospective RAF and RAF-NOACs studies. The primary outcome was defined as the composite of ischemic stroke, transient ischemic attack, systemic embolism, symptomatic cerebral bleeding, and major extracerebral bleeding observed at 90 days after the acute stroke. Results— Of 1810 patients who initiated oral anticoagulant therapy, 371 (20%) underwent bridging therapy with full-dose low-molecular-weight heparin. Older age and the presence of leukoaraiosis were inversely correlated with the use of bridging therapy. Forty-two bridged patients (11.3%) reached the combined outcome versus 72 (5.0%) of the nonbridged patients ( P =0.0001). At multivariable analysis, bridging therapy was associated with the composite end point (odds ratio, 2.3; 95% CI, 1.4–3.7; P <0.0001), as well as ischemic (odds ratio, 2.2; 95% CI, 1.3–3.9; P =0.005) and hemorrhagic (odds ratio, 2.4; 95% CI, 1.2–4.9; P =0.01) end points separately. Conclusions— Our findings suggest that patients receiving low-molecular-weight heparin have a higher risk of early ischemic recurrence and hemorrhagic transformation compared with nonbridged patients.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialised Nursing,Cardiology and Cardiovascular Medicine,Clinical Neurology

Reference33 articles.

1. Perioperative Management of Antithrombotic Therapy

2. Efficacy and Safety of Anticoagulant Treatment in Acute Cardioembolic Stroke

3. Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials

4. Use of Intravenous Heparin by North American Neurologists

5. Resolved: Heparin May Be Useful in Selected Patients With Brain Ischemia

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Choice and Timing of Antithrombotic after Ischemic Stroke, Intracerebral Hemorrhage or Cerebral Venous Thrombosis;CNS & Neurological Disorders - Drug Targets;2024-02

2. Stroke in Patients with Atrial Fibrillation: Epidemiology, Screening, and Prognosis;Journal of Clinical Medicine;2023-12-20

3. Anticoagulation in acute ischemic stroke patients with mechanical heart valves: To bridge or not with heparin. The ESTREM study;European Stroke Journal;2023-07-15

4. Atrial Fibrillation and Stroke;Autonomic Disorders in Clinical Practice;2023

5. Oral Anticoagulant Use and Appropriateness in Elderly Patients with Atrial Fibrillation in Complex Clinical Conditions: ACONVENIENCE Study;Journal of Clinical Medicine;2022-12-14